Seeking Alpha
06 Nov 2026, 17:49 UTC · 1h ago
Smith & Nephew: Sluggish Growth And Shifting Outlook Now Make It Less Attractive (Rating Downgrade)
Impact · against what's priced in
The stock is likely to face downward pressure as the company halves its trading profit growth expectations to 4% and lowers revenue growth guidance to 3%. With the US Orthopaedics segment remaining soft and a valuation of 22x earnings, there are few catalysts to support the current price.
- SNN−0.60
No priced-in read yet





